one8zero8 LLC Makes New $679,000 Investment in Aflac Incorporated (NYSE:AFL)

one8zero8 LLC acquired a new stake in Aflac Incorporated (NYSE:AFL) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 6,564 shares of the financial services provider’s stock, valued at approximately $679,000.

A number of other hedge funds and other institutional investors have also modified their holdings of AFL. Whipplewood Advisors LLC acquired a new stake in Aflac in the 4th quarter valued at about $26,000. Darwin Wealth Management LLC bought a new stake in Aflac in the third quarter valued at approximately $34,000. BankPlus Trust Department acquired a new stake in shares of Aflac in the fourth quarter valued at approximately $34,000. Raelipskie Partnership bought a new position in shares of Aflac during the 3rd quarter worth approximately $38,000. Finally, OFI Invest Asset Management acquired a new position in shares of Aflac during the 4th quarter worth approximately $38,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Insider Buying and Selling at Aflac

In other news, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares in the company, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of the company’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the transaction, the director now owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. This represents a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 55,546 shares of company stock valued at $5,863,616. 0.90% of the stock is currently owned by corporate insiders.

Aflac Stock Up 2.2 %

Shares of NYSE AFL opened at $107.44 on Monday. Aflac Incorporated has a 52 week low of $79.31 and a 52 week high of $115.50. The stock’s fifty day moving average is $105.37 and its 200 day moving average is $107.68. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The stock has a market capitalization of $58.72 billion, a P/E ratio of 11.19, a PEG ratio of 3.24 and a beta of 0.93.

Aflac (NYSE:AFL) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Sell-side analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

AFL has been the subject of several research reports. Piper Sandler cut their price target on Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a report on Friday, February 7th. BMO Capital Markets initiated coverage on shares of Aflac in a research note on Thursday, January 23rd. They set a “market perform” rating and a $111.00 target price for the company. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Morgan Stanley raised their price objective on shares of Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. Finally, Keefe, Bruyette & Woods decreased their target price on Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research report on Wednesday, February 12th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $103.36.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.